VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,331,000 | +29.3% | 69,046 | +70.9% | 0.12% | +27.1% |
Q2 2022 | $1,029,000 | +37.2% | 40,398 | +38.6% | 0.10% | +52.4% |
Q1 2022 | $750,000 | -29.7% | 29,157 | +14.4% | 0.06% | -30.0% |
Q4 2021 | $1,067,000 | +101.3% | 25,487 | +109.2% | 0.09% | +73.1% |
Q3 2021 | $530,000 | -17.3% | 12,184 | -10.1% | 0.05% | -21.2% |
Q2 2021 | $641,000 | +25.2% | 13,551 | +35.8% | 0.07% | +8.2% |
Q1 2021 | $512,000 | -33.7% | 9,982 | -65.4% | 0.06% | -33.7% |
Q4 2020 | $772,000 | – | 28,814 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |